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Monoclonal immunoglobulins with anti-carbohydrate specificity have been found 
more frequently in mice (1)  than in humans  (2-4). It must be recognized, however, 
that the detection of specificity depends upon the choice of possible antigens and the 
numbers  and  characteristics of the  monocional proteins included  in  any screening 
study. Thus, in the survey carried out by Yoo and Franklin (2), 198 IgG, 3 IgA, and 
only  1 IgM were screened against  pneumococcal C  polysaccharide. Freedman et al. 
(4) screened 353 IgG, 87 IgA, and 54 IgM against  115 antigens, including pneumo- 
coccal polysaccharides, mucopolysaccharides, and plant gums. Two IgG and one IgM 
reacted with heparin, and another IgG reacted with several pneumococcal polysac- 
charides  and  two plant  gums  (4).  In  contrast,  the  anti-carbohydrate specificity of 
monoclonal IgM cold agglutinins with anti-I and anti-i specificity is well established 
(5,  6).  Two  other  IgM  cold  agglutinins  have  been  reported:  (a)  one  bound  N- 
acetylneuraminosyl residues (7) and (b) the other lacto-N-tetraose (8). Riesen et al. (9) 
screened 904 myeloma proteins, finding one IgM with specificity for phosphorylcho- 
line that  probably represents anti-carbohydrate. A  monoclonal non-cold agglutinin 
IgM, reacting with Forssman antigen and with glycolipids with terminal nonreducing 
DGalNAc-linked 0t or fl, has also been described (10,  11). 
Employing a  panel of nine acidic Klebsiella polysaccharides and one Enterobacter 
polysaccharide, Hannestad et al. (12) found 4 of 154 monoclonal IgM, each of which 
reacted specifically with a  single Klebsiella  polysaccharide. In contrast, 0  of 73  IgG 
were positive against  the same antigens.  All four IgM had kappa light chains. The 
serum  of one case, T6, contained two monoclonal IgM,  one of which  precipitated 
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with Klebsiella ozenae type AE and with an acidic proteoglycan from cartilage, as well 
as with agar but not agarose; the other monoclonal IgM in the T6 serum was inactive. 
IgM in serum  from patient  B.E.  also reacted  with  K.  ozenae;  IgM  s~ reacted  with  K. 
ozenae  type 6. A  second serum,  Nae (13), also contained two monoclonal IgMt¢, both 
of which precipitated strongly with Klebsiella K11 and weakly with K35 and dextran 
sulfate.  In a  subsequent  study  (14),  116 sera that contained a  monoclonal IgM were 
tested with  17 acidic Klebsiella polysaccharides. Three additional sera were identified: 
Th reacted with Klebsiella K35; We precipitated  K13; Ro reacted with both K12 and 
K 13. All three IgM, when added to suspensions of Klebsiella, caused capsular swelling. 
A  finding  of 7  proteins  with  specificity  for Klebsiella  polysaccharides  of 270  would 
seem a  relatively high frequency. 
In  the  present  study,  we  are  concerned  with  two  additional  IgMx  that  exhibit 
specificity for Klebsiella polysaccharides. One, IgM  wgA, was initially detected because 
of its interaction with Sepharose; the second, IgM  MAY, was discovered in the course of 
a  screening  study  of monoclonal  immunoglobulins  of all  classes  against  a  diverse 
collection of polysaccharides and glycoproteins of bacterial, plant, and animal origin; 
it reacted with a  galactan from the snail Helix pomatm.  By quantitative precipitin and 
precipitin inhibition analyses, the specificity of both of these proteins has been shown 
to be most  closely related  to Klebsiella  polysaccharides with  pyruvylated  galactoses. 
The combining sites of these two proteins, however, differ in specificity. Pyruvylated 
sugars  are  important  antigenic  determinants  of some Klebsiella  K  antigens,  several 
pneumococcal type-specific polysaccharides, and other microbial polysaccharides (15). 
Materials  and Methods 
Case Descriptions.  W.E.A.  (information  obtained  courtesy of Dr.  Richard J.  Hirschman, 
Cabrini Health Care Center, N. Y.), a 33-yr-old white male, was in apparent good health until 
March 1976 when he developed persistent fevers to 103°F, nonproductive cough, anorexia, and 
weight loss. Physical examination disclosed generalized lymphoadenopathy and hepatospleno- 
megaly. Complete blood  count:  hemoglobin,  7.8  g/dl;  white  blood count,  6,300  with  47% 
lymphocytes and some atypical forms, platelets,  155,000. Total serum protein was 9.8 g/dl, and 
electrophoresis demonstrated a  monoclonal spike,  identified immunoelectrophoretically as an 
IgM•.  IgG and IgA levels  were within  normal  limits.  Lymph node biopsy showed a  marked 
infiltration  with  plasmacytic forms, but  the nodal architecture was well  preserved.  Bacterial 
cultures  of the  blood,  urine,  and  stools were  negative.  One  bone  marrow culture  revealed 
Corynebacterium sp:three other bone marrow cultures were negative. 
Although an atypical occult infection could not be excluded, primary macroglobulinemia 
was considered to be the most likely diagnosis, and the patient was treated with chlorambucil 
and corticosteroids. This therapy produced a transient remission. He died three and one-half yr 
after onset of his illness;  autopsy was not performed. 
M.A.Y. is a 7 l-yr-old white male with a background of chronic peptic ulcer disease,  chronic 
cholecystitis and cholelithiasis, and possible inactive pulmonary tuberculosis. He was hospital- 
ized  in  August  1978  for an  atypical  pneumonia  and  sputum  cultures  showed  Haernophilus 
influenzae and Streptococcus pneumoniae. Serum electrophoresis demonstrated a somewhat pauci- 
dispersed  monoclonal  peak  (~1.5  g/dl)  shown  to  be  an  IgMx.  The  concentrations  of the 
immunoglobulins were (in g/dl): IgM 1,512 (normal = 50-200), IgG 771 (normal =  700-1,700), 
IgA 1.50 (normal =  100-350). The peripheral  blood count was normal except for a moderate 
anemia  that  cleared  after resolution of the pneumonia.  Bone marrow aspiration  showed an 
increase in lymphocytes (~20%) consistent with lymphosarcoma. In the subsequent  18 mo, the 
patient has remained asymptomatic without specific therapy. There is no detectable lymphoad- 
enopathy or hepatosplenomegaly and the serum concentration of IgM is unchanged. At this 
time (March  1980) this case is classified  as an asymptomatic plasma cell dyscrasia or so-called 
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IgMMyeloma Proteins.  IgM from serum of patient W.E.A. (IgMWZ^)  1 was purified as follows: 
serum was dialyzed against distilled water for 48 h. The precipitated eugiobulin fraction that 
contained IgM was purified further on Sephadex G-200 in phosphate-buffered saline,  pH 7.2. 
Tubes were pooled, dialyzed against distilled water, and lyophilized or centrifuged to recover 
the precipitated euglobulin. Purity was tested with antisera to y-, a-,/z-, i¢-, and ~k-chains. 
IgM w~a F(ab')2.  F(ab')2 fragments were prepared as described by Miller and Metzger (16). 
The purified  IgM  wgA was reacted  with  trypsin  (EM  Laboratories, Englewood Cliffs,  N. J.) 
1:100 wt/wt for 18 h, at 37°C, in 0.1  M Tris with 0.001  M CaCI2 at pH 8. The reaction was 
stopped with soybean trypsin inhibitor and the digest put on a Sephadex G-200 column with 
0.2 M  Tris-buffer, pH 8.6.  Four well-resolved peaks were obtained, of which the second was 
identified as the F(ab')2 fragment by 10% sodium dodecyl sulfate polyacrylamide gel electro- 
phoresis and by immunological precipitation. 
IgM wEA  (Fc)~.  (Fc).~ was prepared as described by Plaut and Tomasi (17). IgM  wEA was 
digested with trypsin (1:25 wt/wt) for 30 min at 54°C in 0.05 M Tris-HCl buffer, pH 8.1, with 
0.0115 M CaCI2 and put on a Sephadex G-200 column in 0.14 M  NaCI. Four peaks absorbing 
at  280 nm were found. The first  peak,  (Fc)5#, identified  with  antiserum  and by acrylamide 
electrophoresis, was pooled, dialyzed, and lyophilized; it contained a small amount of a second 
band on acrylamide gel electrophoresis. 
IgM from serum of patient  M.A.Y.  (IgM  MA'~) was studied  in whole serum.  IgM  raAv was 
originally detected by screening in agarose gel; it was recognized initially by its reaction with 
Helix pomatia galactan, a polysaccharide with which IgM  wEA also reacted. An IgMI¢ myeloma 
that did not react in screening tests, IgM  sc°, served as a control. 
Polysaccharides.  The following polysaccharides were studied: commercial Bacto and special 
agar (Difco Laboratories, Detroit, Mich.) and successive fractions prepared from it, as described 
by Duckworth and  Yaphe  (18),  by extraction  with  water at  20 and  50°C, and  the residue; 
commercial agarose  (Fisher  Scientific  Co.,  Pittsburgh,  Pa.);  galactans  from the snails  Helix 
pomatia  (19-22); Arianta arbustorum and their first stages of partial periodate oxidation and Smith 
degradation (23) Cepaea nemoralis and Biomphalaria  glabrata  (24); Larch arabinogalactan (25) and 
pig  pneumogalactan  (26,  27)  from  Dr.  Niel  Glaudemans  (National  Institutes  of Health, 
Bethesda,  Md.);  polysaccharides from Klebsiella  K7  (28),  K21  (29),  and  K32  (30),  Rhizobiura 
trifolii TA 1 (31), and types IV, XIV, and XXXII pneumococcal polysaccharides (32) through 
Dr.  Michael  Heidelberger,  New York University College of Medicine,  New York; Rhizobium 
trifolii strain U226 (33) and KlebsieUa  K30 (34) and K33 (35) from Professor Bengt Lindberg, 
University of Stockholm,  Stockholm;  pneumococcal  group  C  polysaccharide  from  the  late 
Professor Sam  M.  Beiser,  Columbia  University,  New York; xanthan  gums and  their  sulfo- 
methylated products from Dr. I. W. Cottrell (36), Kelco Div., Merck & Co., Inc., Rahway, N. 
J.;  dextran sulfate  (Pharmacia Fine Chemicals,  Div. of Pharmacia,  Inc., Piscataway, N. J.); 
heparin, keratosulfate (37), a heparin analogue from alginic acid (38), and chondroitin sulfate 
(Sigma Chemical Co., St. Louis, Mo.); dextran (39) and various blood group B and I substances 
(40-44). 
Inhibitors.  Sodium pyruvate (ICN Nutritional Biochemicals Div., Cleveland, Ohio), sodium 
lactate (neutralized from Mallinckrodt  lactic acid), sodium propionate (Fisher Scientific Co.), 
D- and L-fucose (Schwarz Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.), D-galactose 
(Eastman Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.), L-galactose (Sigma 
Chemical Co.), o-mannose (Pfanstiehl LaboratorieS, Inc., Waukegan, II1.), and methyl a- and 
,/~-D-galactosides  from  Dr.  A.  B.  Pardee  (Harvard  University,  Boston,  Mass.)  were  used  in 
various amounts as possible inhibitors of the various precipitin reactions,  A sample of the R 
isomer of methyl  4,6-O-(1-carboxyethylidene)  ~-o-galactopyranoside  (4,6pyDGal]~)  (45) was 
kindly provided  by  Professor  Bengt  Lindberg  and  Dr.  Ingemar Kvarnstr/Sm  (University of 
Stockholm), and a sample of the R  and S isomers of methyl 4,6-O-(1-carboxyethylidine a-n- 
galactopyranoside  (4,6pyDGalo 0  from  these  workers  through  Dr.  Michael  Heidelberger.  D- 
I Abbret,iations used in this paper: DGal, D-galactose; oGlc, D-glucose; DMan, D-mannose; 3,4pyDGalot, 3,4- 
O-(l-carboxyethylidine) a-D-galactopyranoside, 3,4pyDGal]~, 3,4-O-(l-carboxyethylidine) /~-D-galactopy- 
rauoside: 4,6pyoGalot, 4,6-O-(l-carboxyethylidine) Ot-D-galactopyranoside;  4,6pyDGal/~, 4,6-O-(1-carboxy- 
ethyl idine) ,B-D-galactopyranoside,  IgM  MAy, lgM from serum of patient M.A.Y.; IgM  wv'A,  IgM from serum 
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Galaetose-l-phosphate, v-galactose-6-phosphate, and D-glucose-l-phosphate (Sigma Chemical 
Co.) were used as the potassium salts. 
Immunochemical Methods.  Quantitative precipitin studies were carried out in the usual manner 
(46-48).  Varying quantities of polysaccharide antigens were added to  ~8/Lg N  of purified 
IgM  wEg or its F(ab')2 and (Fc)~ fragments in a  vol of 25 lal, and to 25/Li of a  1:5 dilution of 
IgM  M^v serum in 3.0-ml conical centrifuge tubes. The total volume was adjusted to 350/~! with 
0.15  M  NaCI. The contents of the tubes were mixed, placed at  37°C  for  1 h, placed in the 
refrigerator for  1 wk and were mixed twice daily. The tubes were centrifuged, washed twice 
with saline, and analyzed for N by the ninhydrin method (44). 
Quantitative precipitin inhibition tests were set up by adding various quantities of inhibitor 
to ~8/~g N  purified IgM  we^ or to 25/tl of a  1:5 dilution of IgM  MAy serum. After 30 min at 
37°C, a  quantity of antigen giving maximum  precipitation was added. The contents of the 
tubes were mixed, placed at 37°C for I h, and placed in the refrigerator for 1 wk. Centrifugation, 
washing, and  analysis were as above.  The  capacity of the F(ab')2 and  (Fc)~ fragments of 
WEA  IgM  to  precipitate, to coprecipitate, and  to  inhibit precipitation was  also assayed. For 
--  --  W  inhibition assays with purified IgM  E^ and the pyruvylated sugars and other charged com- 
pounds, special care must be taken to ensure that reactions are carried out close to neutrality. 
In some assays, at which the pH was 4.7, negative values for inhibition were obtained because 
a  larger proportion of the added IgM was precipitated by antigen. Only determinations are 
reported that were at proper pH. 
Coprecipitation Studies (47).  To  4-/zg  N  portions of IgM  wE^  in  a  series of 3-ml  conical 
centrifuge tubes, 6.6 #g N  of the F(ab')2 of 6.4/~g N of the (Fc)~d'ragments of IgM  wE^ were 
added,  followed by  various quantities  of KlebsieUa K30.  The  tubes  were  then  analyzed  as 
described above. 
Absorption Studies.  The identification of the monoclonal peak ascribable to the anti-K21 in 
IgM  May serum was accomplished by the procedure used by Tiselius and Kabat (49):  to ,50/~1 
of undiluted IgM  MAy serum, 20 #g of Klebsiella K21 in 50/LI saline was added. To a second 50- 
/~1 sample of IgM  M^Y serum, 50/LI of saline was added. After 1 wk in the refrigerator, the tubes 
were centrifuged, decanted, and the supernates examined by electrophoresis on cellulose acetate 
(50). 
Immunoelectrophoretic Studies.  Serum  of IgM  M^v was placed in  two wells and  subjected to 
electrophoresis in  agar.  Arcs were developed in  the  bottom  trough  with  horse  anti-human 
serum,  in  the middle trough  with  goat anti-human  IgM, and  in the top trough  with Helix 
pomatia galactan. 
Helix pomatia, Cepaea nemoralis galactans, and dextran were placed in wells electrophoresed in 
agar,  and  IgM  MAy or QUPC52,  an  anti-al--*6 dextran  myeloma protein,  were  placed  in 
appropriate troughs to develop bands. Human serum was also subjected to electrophoresis to 
serve as a reference. 
Results 
Quantitative  Precipitin Studies.  Sepharose is manufactured from the agar component 
agarose,  a  linear  polysaccharide  with  alternating  D-galactose  and  3,6  anhydro-L- 
galactose  residues.  Various  agarose,  agar,  and  galactan  preparations  were  chosen, 
therefore, as the starting polysaccharides for analysis of the IgM  wEA binding specific- 
ity. The results of these precipitin analyses are shown  in  Fig.  1 A.  It  is evident that 
commercial agarose was inactive in the range tested, but the Bacto agar preparations 
reacted. The 20°C aqueous extract was more active than the subsequent 50°C extract 
(18),  and  both  were  more  potent  than  the  original  Bacto  agar  on  a  weight  basis. 
Identical  results  were  obtained  with  fractions  of Noble  agar  (Difco  Laboratories) 
(data not shown). 
IgM  wEA also reacted with the galactan from Helix pomatia  (19-22)  and its reactivity 
was increased by one stage of partial periodate oxidation and Smith degradation (23); 
periodate oxidation and  Smith degradation removes all of the L-galactose, leaving a KABAT ET  AL.  983 
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FIG.  I.  Quantitative precipitin reactions  of IgM  wEA (A) and  IgM  MAy (B) with various polysac- 
charides.  The graph at the right in (A) shows the reactions of the 20°C extract of agar and Ktebsielta 
K21 on a scale using 20 times as much antigen. Symbols: 0t, Klebsiella  K21 ;0, Klebsiella  K30 native; 
(~, Klebsiella K33 native; Q, Bacto agar 20 ° extract; At Helix pomatia galactan 1st Smith degradation; 
A, tlehbc pomatia  galactan;  4, Capaea nemoralis galactan; 8,  Bacto agar 50°C extract; i,  Rhizobium 
trifolii U226; El, dextran sulfate;  ~, Bacto agar; 17Y, Bacto agar extracted residue; I~, Rhizobium  trtfolii 
TAI; ~, Klebsiella  K32;  (), Klebsiella  K7; IYl, pneumococcus type S XXVII; I, pneumococcus type 
S IV; 171, pneumococcus type S XIV; ×, Pneurnococcus C; r"l, agarose; @, heparin; V, heparin analogue 
from alginic acid; it, Arianta arbustorum galactan;/Ix,  Arianta arbustorum galactan 1st Smith degradation; 
I~I,  arabinogalactan  (Larch);  lal, pneumogalactan;  ~,  keratosulfate;  /'~,  chondroitin  sulfate;  A 
Biomphalaria  glabrata galactan; [], gum ghatti al---+6. 
polysaccharide composed entirely of D-galactose. The periodate-oxidized and Smith- 
degraded  Helix pornatia galactan  is  about  as  active  as  the  20°C  extract  of agar. 
However, the galactan of Cepaea nemoralis without Smith degradation was as active as 
the 20°C agar extract. Galactans from the related species, Arianta arbustorurn and its 
first stage of periodate oxidation, and Smith degradation (23)  and a  native galactan 
from Biomphataria glabrata (24), were completely inactive. Larch arabinogalactan (25), 
known to react with various mouse myeloma proteins with anti-galactan activity (1), 
was  inactive as  were several  blood  group  I  (OG  20%  from  10%  [40,  41]);  BI  (Tij 
phenol  insoluble [42]);  and  B  (Beach phenol  insoluble [41])  active substances with 
terminal nonreducing fl- and a-linked o-galactose. 
The finding that  IgM  wEA reacted strongly with the 20°C  agar extract suggested 
that its specificity might involve sulfate or pyruvate groups known to be substituted 984  KLEBSIELLA-SPECIFIC  HUMAN MONOCLONAL MACROGLOBULINS 
to varying extents on the linear agarose chain  (18, 51). However, when a  number of 
sulfated polysaccharides were examined,  they were found to be completely inactive. 
For example, heparin, keratosulfate  (37), chondroitin sulfate, xanthan gum (36), and 
their  sulfomethylated  compounds  (36)  all  failed  to  precipitate  IgM  wEA.  However, 
IgM  wE^ did react with dextran sulfate (Fig.  1 A). The reaction was much more readily 
inhibited by excess antigen and, at the maximum, precipitated only 73% as much N 
as did the 20°C and 50°C agar extracts and the Helix and Cepaea galactans. 
Quite different results were obtained when eight polysaccharides known to contain 
pyruvylated  sugars  were  studied.  Only  those  with  3,4-  and  4,6-pyruvylated-DGal 
residues  were found to react  with  IgM  wgA (see Table I  for structural  comparisons). 
Klebsiella  K30  and  K33  were  the  most  active,  l/a0 as  much  being  required  for 
comparable precipitation  as the 20°C aqueous agar extract,  the first periodate stage 
of Helix pomatia, or Cepaea nemoralis  polysaecharide  (Fig.  1 A). The Klebsiella K30 and 
K33 ligands have 3,4-pyruvylated terminal  DGal-linked ,81---.4  to DMan in the main 
chain. The Rhizobium trifolii  polysaceharides varied in activity; the U226 preparation 
reacted as well as whole agar, whereas the TA 1 reacted very weakly despite the fact 
that both have pyruvate linked 4,6 to terminal nonreducing DGal. The Klebsiella K21 
polysaccharide  (29)  also  reacted,  but  ~10  times  as  much  K21  as of 20°C  aqueous 
agar extract was required for 50% precipitation of the myeloma antibody. In Klebsiella 
K21, the pyruvic acid is linked 4,6 to terminal  nonreducing DGal-linked al---~4 to D- 
glucuronic acid in the main chain and, thus, shows similarities  to the pyruvyl group 
in agar except for being terminal. 
IgMMAV: the  second  myeloma  protein  was  detected  in  a  screening  program  for 
identifying human myeloma proteins that react with various polysaccharides. One of 
the polysaecharides in the screening mixtures was the Helix pomatia galactan. IgM  MAy 
gave a  good precipitate with the mixture and was found to precipitate  only with the 
Helix pomatia polysaccharide. Fig.  1 B shows the quantitative  precipitin  findings with 
IgM  MAy. Reactions with the agar fractions differed from those of IgM  wEA in that the 
50°C aqueous extract was more active than that made at 20°C. Helix pomatia and its 
TABLE I 
Structures of Pyruvylated Monosaccharides in  Various Polysaccharides 
Polysaccharide  Structure and linkage of pyruvylated sugar 
1 Klebsiella  K30 (34) 
2 Klebsiella K33 (35) 
3 Klebsiella K21 (29) 
4 Rhizobium trifolii (31,33) 
5 Agar (51) 
6 Klebsiella K7 (15) 
7 Klebsiella K32 (30) 
8  Pneumococcus type S IV (52-55) 
9  Pneumococcus type S XXVII (56) 
Pyruvate on 3,4 of DGalfll--q,6 linked to [---*4DManp----~]  of main 
chain 
Pyruvate on 3,4 of DGalfll--*6 linked to [--~4DManp--*]  of main 
chain 
Pyruvate on 4,6 of lateral nonreducing end group of DGalal---~4 
to [---~3DGlcA  t--~3] 
Pyruvate on 4,6 of lateral nonreducing nGal linked/~1---3 to a 
4,6 pyruvylated ODGIcp  residue 
Pyruvate on 4,6 of [----~3DGal  l---~] of main sugar chain 
Pyruvate on 4,6 of [---~3DGIcl---~]  of main chain 
Pyruvate on 3,4 of [----~2LRhaa  1---*] of main chain 
Pyruvate presumably on 2,3 of nGal 
Pyruvate on 4,6 of [-*3DGIcNAc/~I--*]  of main chain 
For a detailed analysis of structures of Klebsiella and other polysaccharides and their cross-reactions in anti- 
pneumococcal and anti-salmonella sera, see reference (15). KABAT ET AL.  985 
first  stage  of periodate oxidation and  Smith degradation  reacted as they did with 
IgM  wEA. IgM  MAY clearly differed from IgM  wEA in that Klebsiella K21 reacted 20 times 
better than the Helix first-stage periodate fraction and 80 times better than the 20°C 
aqueous agar extract. The most striking finding was that the Klebsiella K21, K30, and 
K33 polysaccharides were all equally active per unit weight, giving a single quanti- 
tative  precipitin curve  (Fig.  1B).  Rhizobium trifolii TA1  polysaccharide, which  was 
essentially inactive with IgM  wzA, reacted strongly; it and U226 were equally potent 
and one-seventh as active as K2 I. 
Purified  (8.8  #g  N)IgM  sc°  did  not  give  precipitin  reactions  with  the  various 
Klebsiella antigens over the range used in Fig.  1 A  and  B, nor with dextran sulfate, 
heparin, agar, etc. 
Absorption Experiments.  Because IgM  MAy was studied in whole serum, it was neces- 
sary to demonstrate specific removal of the monoclonal gamma peak from the serum 
electrophoretic patterns by addition of antigen. Addition of an amount of Klebsiella 
K21, which gave maximum precipitation, eliminated the monoclonal peak. Quanti- 
tative estimation of the concentrations of IgM, IgG, and IgA in the serum before and 
after addition of Klebsiella K21 confirmed the removal of >95% of the IgM. The IgG 
was decreased ~20%; IgA was unchanged. Addition of Klebsiella K21 to normal serum 
decreased the IgG concentration by 1 I% but did not change the IgM concentration. 
Addition of Klebsiella K7 to IgM  MAY serum or to normal serum did not reduce the 
concentrations of IgM, IgG, or IgA. 
Immunoelectrophoretic Studies.  The Helix pomatia galactan, with which the serum that 
contained  IgM  MAy  was  found  to  react  in  the  original  screening,  was  shown  by 
immunoelectrophoresis to be reacting specifically with the IgM. 
Electrophoresis of the various galactans has shown them to be charged molecules 
(23).  Helix  pomatia galactans  were  highly  negatively  charged  (23)  and  contained 
galactose-6-phosphate; Weinland (57) has isolated it and a trisaccharide that contains 
galactose-6-phosphate  from  the  galactan.  Fig.  2  shows  that  the  galactans  of Helix 
pomatia  and  Cepaea nemoralis are  highly  negatively  charged,  moving  as  rapidly  as 
prealhumin in immunoelectrophoresis, whereas the dextran is seen to react with anti- 
dextran  alongside  of its  well.  The  Biomphalaria glabrata (23)  and  Arianta arbustorum 
galactans may contain another constituent, the nature of which is unknown (Bretting, 
H., N. F. Whittaker, E. A. Kabat, K. KSnigsmann-Lange, and H.-J. Thiem. Manu- 
script in preparation). 
Inhibition Assays.  Inhibition  studies  of the  precipitin  reactions  between  IgM  wEA 
and the 20°C agar extract, the Helix pomatia galactan and its first stage of periodate 
oxidation and Smith degradation, were carried out with neutralized pyruvic, lactic, 
and  propionic acids, with various monosaccharide glycosides and  oligosaccharides, 
with the neutralized R  isomers of methyl 4,6pyDGala and 4,6pyDGal/3 (45), with the 
S  isomer  of methyl  4,6pyDGala,  and  with  D-galactose-l-phosphate,  D-galactose-6- 
phosphate, and D-galactose-1-phosphate. 
Fig.  3 A shows that  the precipitin reaction of IgM  wzA with the 20% agar extract 
was inhibited by sodium pyruvate and to a  lesser degree by sodium lactate; sodium 
propionate was inactive. D-galactose-6-phosphate, D-galactose- 1-phosphate, n-glucose- 
l-phosphate, and D-glucose-6-SO4 inhibited less strongly than sodium pyruvate and 
about  as  well  as  sodium  lactate.  The  precipitin  reaction of IgMWEA-Helix pomatia 
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F~o.  2.  lmmunoelectrophoretic pattern  showing charge on  Helix pomatia and  Capaea nemoralis 
galactans. The wells from top to bottom contain normal human serum, dextran N279, Capaea 
nemoralis, and Helix  pomatia galactans. The top trough contains horse anti-human serum; the second 
trough is empty; the third contains myeloma anti-dextran QUPC-52; the fourth is empty; and the 
fifth contains IgM  w•A, 
sodium lactate and sodium propionate were inactive (data not shown). The reaction 
of  IgM  wEA  with  the  first  stage  of  periodate-oxidized  and  Smith-degraded  Helix 
galactan was only minimally inhibited by sodium pyruvate, and the reaction appeared 
to  be  less specific  (data  not  shown).  No  inhibition  was  obtained  with  the  various 
monosaccharide glycosides and  oligosaccharides  (Fig.  3 A). The methyl 4,6pyDGal/3 
and  4,6pyDGala  R  isomers  were  equally  active  and  >20  times  more  active  than 
sodium pyruvate on a  molar basis in inhibiting precipitation of the IgM  wEA by agar, 
but the S isomer gave no inhibition. The small graph at the right of Fig. 3 A gives the 
inhibition  by methyl 4,6pyDGala and 4,6yoGalfl R  isomer and methyl 4,6pyDGala S 
isomer of precipitation of IgM  wEA by agar on a  25-fold expanded scale. 
IgM  MaY.  Fig. 3 B shows that pyruvate was better than lactate and propionate in 
inhibiting the precipitation of IgM  wEA by Klebsiella K21 polysaccharide. However, as 
with IgM  wEA, the R  isomers of 4,6pyDGala and 4,6pyDGalfl were equally potent and 
150  times  more  active  than  pyruvate  in  inhibiting  the  Klebsiella  K21  precipitin 
reaction;  the S  isomer of 4,6pyoGala was inactive at an amount of R  isomer, giving 
50% inhibition.  The graph at the right of Fig. 3 B gives the inhibition  data with  the KABAT  ET  AL. 
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FtG. 3,  Inhibition  by methyl glycosides of neutralized pyruvylated I~Gal by sodium pyruvate, 
lactate,  and propionate,  and by various other compounds of precipitation of IgM TM by agar (A)  y  -  _  MA  and IgM  (B) by Klebszella  K21. Symbols: &, methyl 4,6pyoGala R isomer; A, methyl 4,6pyDGal/~ 
R  isomer; V, methyl 4,6pyDGala S isomer; O, sodium pyruvate; (D, glucuronic acid; O, D-glocose-6- 
sulfate; ~9, sodium lactate; ~, sodium propionate;  tD, L-fucose; (), D-fucose; I--1, oGal; [1, L-galactose; 
ill,  DGIc;  ~,  lactose; ~,  DMan;  ~,  methyl a-DGal; t~,  methyl /~-DGal;  t'~,  L-rhamnose; ~,  D- 
galactose-6-phosphate; ~, D-glucose- l-phosphate; ~,  D-galactose- 1-phosphate. 
methyl 4,6pyoGala and 4,6DGalfl R  isomer and methyl 4,6pyoGala S isomer on a 25- 
fold  expanded  scale  so  that  the precision  of the data  becomes  evident.  Unlike  the 
findings with IgM TM,  galactose-6-phosphate,  galactose-l-phosphate,  and glucose-1- 
phosphate gave no inhibition in the amounts used, nor did methyl a  or floGal. 
Coprecipitation Studies.  Fig. 4 shows the quantitative precipitin curves obtained by 
adding varying quantities ofKlebsiella  K30 polysaccharide to mixtures that contained 
4.0/~g N ofIgM TM  plus 6.6/~g N of the F(ab')z or 6.4 ~g N of the (Fc)5~. It is evident 
that some of the F(ab')2 copreeipitates  in an IgMWEA-Klebsiella  K30-specific  precipi- 
tate, whereas none of (Fc)s# coprecipitates.  The  (Fab')z fragment contained a second 
band on acrylamide.  The proportions of antigen, precipitating antibody, and copre- 
cipitating antibody for removing all coprecipitating antibody are difficult to establish. 
Fig.  4  indicates  that  the  intact  2.75  ~tg  N  of intact  IgM TM  has  a  coprecipitating 
capacity  for only 0.75/xg  N  (Fab')z.  If the amounts  of IgM TM  and Klebsiella  K30 
polysaccharide  were  doubled,  more  (Fab')2  N  but  no  Fcs  was  taken  up  (data  not 
shown). 988  KLEBSIELLA-SPECIFIC  ttUMAN  MONOCLONAL  MACROGLOBUI,INS 
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l"[c.  4.  Coprecipitation curves obtained by adding various amounts of Klebsiella K30 polysaccha- 
ride  to 6.0 /~g N  of (Fab')2  (O),  and  (Fc)r,/t  WEA  •  WEA  (A), of IgM  plus  4.0 /.tg N  of intact  IgM  as 
compared with that of 4.0 btg N of IgM wEA alone (C)). 
Discussion 
The specificity of IgM  wEA was first recognized by its absorption to Sepharose and 
its  reaction with  agar but  not  agarose.  The various fractions of agar described by 
Duckworth  and  Yaphe  (18)  reacted  differently,  the  most  active  being  the  20°C 
aqueous extract. Agar has been shown  to contain pyruvate-linked 4,6 to a  3-1inked 
DGal in the main chain made up of alternating  1---~3-1inked/~-DGal and  1---*4-1inked 
anhydro c~-L-galactose.  Agar also contains sulfate groups, and the various fractions of 
agar contain different proportions of sulfate and pyruvate; agarose is essentially free 
of both pyruvate and sulfate (51). The precipitin reactions of IgM  wEA with the various 
Klebsiella  polysaccharides shown in Fig.  1 A provide strong evidence that the combin- 
ing site of the IgM  wgA is most specific for a pyruvylated terminal nonreducing DGal- 
linked fl, but do not permit a decision as to whether the pyruvate is 3,4- or 4,6-1inked. 
Quantitative  precipitin  data  with  either polysaccharides from Klebsiella  K30,  K33, 
K21, K7, K32, and from pneumococci of types IV and S XXVII, all of which contain 
pyruvate linked in various ways (Table I), show that precipitation only occurred with 
K30 and K33 with 3,4-pyruvylated DGal linked/3, one preparation of Rhizobium trifolii 
U226 with 4,6-pyruvylated DGal linked/~, and K21 with 4,6-pyruvylated sGal linked 
a. K30 and K33 were ~ 10 times more potent, and Rhizobium trifolii U226 was 3 times 
less active/unit weight as compared with the 20°C extract of agar. Klebsiella K212 was 
1/100 as active/unit weight as Klebsiella  K30 or K33. None of the sulfated polysac- 
charides  except  dextran  sulfate  precipitated  with  IgM  wwA, and  precipitation  with 
dextran sulfate did not resemble the usual precipitation curve with IgM and potysac- 
charides, in that it was readily inhibited by a relatively slight excess of dextran sulfate 
and all of the IgM  wgA was not precipitated. The precipitin data are best interpreted 
as indicating that  the antibody-combining sites are most specific for a  3,4- or a  4,6- 
pyruvylated terminal nonreducing nGal linked/3. The very poor reaction of K21  is 
probably  attributable  to  the  pyruvyl  group  of DGal  being  linked  c~.  The  poorer 
reaction  of  the  Rhizobium  trifolii  polysaccharide  U226,  which  also  has  terminal 
4,6pyDGal/~,  is  not  clearly interpretable  because  it  could  be either attributable  to 
2 Dr. Arepalli S. Rao in this laboratory has subsequently noted that a solution of Klebsiella K21prepared 
by Dr. M. Heidelberger ~8 yr ago reactsidentically-withigM MAy but does not react with IgM  wEA. It also 
may be that the reaction of IgM wzA with Klebsiella K21  (Fig. 3, right hand graph) is more sensitive to pH; 
this is being studied. KABAT ET AL.  989 
cross-reactivity between 4,6pyDGalfl in a  3,4-O-(1-carboxyethylidine)fl-o-galactopy- 
ranoside  (3,4pyDGalfl)  site  or  possibly  to  steric  hindrance  from  the  adjacent  4,6- 
pyruvylated-D-glucose (oGlc) residue. The difference in reactivity of the two strains of 
Rhizobiurn  trifolii  (31,  33)  is  not  clear, although  both  have the same  repeating unit 
structure,  but  Heidelberger et  al.  (15)  have  noted  strain  differences in  the  cross- 
reactions of Rhizobia. 
That pyruvylated sugar is involved in the specificity of the reaction is supported by 
the finding that pyruvate is a  better inhibitor than lactate, o-galactose-l-phosphate, 
o-galactose-6-phosphate,  D-glucose-l-phosphate,  and  o-glucose-l-sulfate,  and  that 
propionate did not  inhibit  precipitation of IgM  wgA by agar over the range studied 
(Fig.  3A).  The R  isomers of methyl 4,6pyDGalfl and  4,6pyDGala are >20 times as 
potent as pyruvic acid, whereas the S isomer of methyl 4,6pyDGala did not inhibit; 
no inhibition was obtained by DGal and its methyl a  and fl galactosides, even at  100 
/~mol, although the R  isomers of 4,6pyoGala and 4,6pyoGalfl gave 50% inhibition at 
0.2/Lmol. Heidelberger et al.  (15)  showed that sodium pyruvate inhibited the cross- 
reaction of the UNZ strain of Rhizobium trifolii with type XXVII anti-pneumococcal 
horse sera more effectively than sodium lactate and sodium propionate. Despite the 
clear-cut involvement of the charged pyruvyl group, the IgM  wEA site may accom- 
modate  a  oGal  determinant  substituted  by  other  negatively  charged  groups  as 
evidenced by the strong reaction with Helix pomatia  and  Cepaea nernoralis galactans, 
and by the increased reactivity of the Helix pomatia  galactan  that  resulted from the 
removal of LGal by periodate oxidation and Smith degradation. The reaction with 
the Helix  galactans  was  specific and  charge-related  because  the  uncharged  Larch 
arabinogalactan and pneumogalactan did not react with IgM  wzA. The isolation of a 
t risaccharide from Helix pomatia  (57), one residue of which was galactose-6-phosphate, 
together  with  the  findings  that  galactose-6-phosphate,  galactose-l-phosphate,  and 
glucose-l-phosphate  show  some  inhibition,  although  less  than  seen  with  sodium 
pyruvate, indicate that the phosphorylated galactose is probably reacting in the site. 
The  positively charged  moiety  on  the  Arianta  arbustorum  and  Biomphalaria  glabrata 
polysaccharides may be a  factor in their non-cross-reactivity. 
The structure of the Helix pomatia galactan was inferred by O'Colla (21) to be a 3,6 
branched dichotomous structure from four successive stages of periodate uptake and 
formic acid assays, each followed by phenylhydrazine treatment (Barry degradation) 
and  from the finding of equal  proportions of 2,4-dimethyl and  2,3,4,6-tetramethyl 
galactose.  However, recent methylation studies  have shown it to have a  somewhat 
more  complex  structure  and  from  immunochemical  studies,  (H.  Bretting,  N.  F. 
Whittaker, E. A. Kabat, K. Ki~nigsmann-Lange, H.-J. Thiem. Manuscript in prepa- 
ration.) the Helix pomatia  and Cepaea nemoralis galactans must differ in structure from 
those of Arianta arbustorurn and Biomphalaria glabrata. 
The finding that  the  R  isomers methyl 4,6pyDGala and  4,6yDGalfl are of equal 
potency as inhibitors of the precipitin reaction of IgM  wzA by agar, whereas Klebsiella 
K21  polysaccharide with 4,6pyDGala is  100  times less  active  2 per unit weight  than 
Klebsiella  K30 and K33 with 3,4pyDGalfl structure, suggests either that the IgM  weA 
site may be more specific for the 3,4pyoGal present in the K30 and K33 polysaccha- 
rides and that the poorer reaction with the K21 polysaccharide is due to the 4,6pyoGal 
not fitting as well into the site, and/or that a fl-linkage creates less steric hindrance 990  KLEBSIELLA-SPECIFIC  ItUMAN MONOCLONAL MACROGLOBULINS 
than  an  a-linkage  with  the  intact  polysaccharides, which  is  not  seen  in  inhibition 
assays with the methyl 4,6pyoGala and 4,6pyoGal/3. 
IgM  M^v has a combining site specific for pyruvylated oGal but differs markedly in 
its reaction pattern from IgM  wEA, although it reacts similarly to IgM  wE^ with Helix 
pornatia galactan  and  its  first stage of periodate oxidation and  Smith  degradation; 
IgM  w~A reacts better with the 50°C than with the 20°(3 agar extract. However, unlike 
IgM  wEA, glucose-1-phosphate, galactose-1-phosphate, and galactose-6-phosphate did 
not inhibit with IgM  MAy over the range in which they were as active as lactate. It also 
reacts very strongly with small amounts of Klebsiella  K21, whereas IgM  wEA required 
very large amounts of K21 for precipitation  2 (Fig. 1 B). The combining site of IgM  MAY 
appears to be smaller and perhaps less specific than that of IgM  w~A in that Klebsiella 
K30 and K33 with 3,4-1inked terminal nonreducing vGal-linked/~ react as well per 
unit weight as K21 with 4,6-1inked terminal nonreducing DGal linked a. This finding 
would also be consistent with the strong reactivity oflgM  MAY with the polysaccharide 
of Rhizobium  trifolii TA1, with which IgM  w~'A did not react, and also with the poorer 
reactivity of IgM  wEA than IgM  MAY with U226;  thus,  if the failure to react and  the 
poorer reactivity of IgM  wEA is caused by steric hindrance of the adjacent pyruvylated 
DGlc, this effect is not seen with IgM  MAy, suggesting a site more accessible or smaller 
than that  of IgM  wEA. The inhibition data that  show that  the R  isomers of methyl 
4,6pyoGala and 4,6pyDGal/~ are equally effective as inhibitors on a molar basis (Fig. 
3 B, right hand graph) also show that the IgM  MAy site is not sensitive as to whether 
the  linkage  of the  4,6-pyruvylated-DGal to  the  next  sugar  is  c~  or /~.  Thus,  with 
IgM  MAY, unlike IgM  wv'A, the site is equally accessible to 4,6pyDGala and 4,6pyoGal/3 
on a  high molecular weight polysaccharide or as the methyl glycoside. The present 
study  is  limited  because  the  3,4pyDGala  and  3,4pyoGal/~  were  not  available  to 
compare their inhibiting power with the 4,6-pyruvylated-oGal. Because IgM  wEA and 
IgM MAy are  both  myeloma proteins,  their exact  specificity is  not  known  and  the 
possibility always exists that some unexpected more highly specific reactant may be 
found. However, the amounts of the active Klebsiella antigens giving precipitation are 
so small, and the R  isomers of 4,6pyoGala and 4,6pyDGal~ as inhibitors, so active, 
whereas the S isomers are inactive, that this seems less likely for this system. 
Neither DGal, its methyl a- and/~-glycosides, nor any of the other neutral sugars 
tested  gave  any  inhibition  over  the  range  used  with  either  IgM  wEA  or  IgM  MAY, 
suggesting that  the reaction with the Helix pomatia  and  Cepaea nemoralis galactans is 
attributable  to  the  negative  charges  on  these  galactans.  It  will  be  important  to 
determine whether removal of the charged groups eliminates their precipitin activity. 
Unlike the findings with IgM  wEA, galactose-6-phosphate, gaIactose-1-phosphate, and 
glucose-1-phosphate did not inhibit precipitation. 
To map the combining sites more precisely, it will become of great importance to 
obtain  oligosaccharides  from  various  Klebsiella  types  containing  3,4pyDGala, 
3,4pyDGal/~, 4,6pyDGala, and 4,6pyoGal¢/and to compare these as inhibitors. 
The 4,6 and 3,4 pyruvyl groups are chiral and each may be linked in two forms 
that  are  space  isomers  termed  R  and  S  (45).  Garegg  et  al.  (58)  have  recently 
determined the orientation of the 3,4- and 4,6-pyruvylated-oGal in various Klebsiella 
polysaccharides by nuclear magnetic resonance measurements. K30 and K33 with 3,4 
pyruvate are both  in  the S  configuration, whereas  K21  and Rhizobium  trifolii  U226 
with  4,6  pyruvate  were  in  the  R  form;  however,  in  the  4,6  polysaccharides,  the KABAT ET AL.  991 
orientation of the methyl group was equatorial and in the 3,4 compounds was endo 
relative to the acetal ring so that they all have the same conformation despite the 
different linkage. 
It is of significance that all of the pyruvylated polysaccharides that reacted with 
IgM  wzA and IgM  M^v are known to have the methyl group of the pyruvate moiety 
equatorial and the carboxyl group axial to the plane of the acetal ring (58) and that 
this is also the orientation in the R  forms of methyl 4,6pyDGala and 4,6pyDGalfl. 
Thus, the precipitation and inhibition involve the same spatial relationships of the 
determinant  and  inhibitors.  Because the S  isomer of methyl 4,6pyDGalct does not 
inhibit with IgM  wv'A and IgM  MAy nor with Klebsiella  K11-anti-Klebsiella K11  (59), 
these  reactions  are  highly  specific,  providing  unusually  strong  evidence  for  the 
specificity of the myeloma sites being actually directed toward 3,4- or 4,6-pyruvylated- 
DGal.  Klebsiella  KI1  polysaccharide also  contains the  R  form of 4,6pyDGala  (59) 
(Table I). Inhibition studies with the R  and S isomers of methyl t~- and fl-glycosides 
of 3,4pyDGal will, therefore, be important for characterizing the sites of IgM  weA and 
IgM  M^v. 
The  specificity of the  previously  reported  IgM  Nae  (12,  13)  could  also  involve 
pyruvylated galactose because it reacted strongly with Klebsiella K1 l, which contains 
terminal 4,6-pyruvylated-DGal-linked a 1---~4 to a --~3-1inked o-glucuronic acid in the 
main chain (15),  but a  reaction was apparently not seen with K21  (12) in which the 
4,6-pyruvylated-DGal is also joined al--*4  to a  ---~3-1inked o-glucuronic acid in the 
main chain (Table 1); K35, with which IgM  Nae and IgM  Th (60) reacted, and K12 and 
K13, with which IgM  R° and IgM  we reacted, also contain pyruvic acid and galactose; 
in K12 (60)  the 4,6-pyruvylated-DGal is linked ill--*4 to o-glucuronic acid, which is 
linked fll---~6 to a main chain. The structure of K13 has not been reported. The other 
three IgM proteins reacting with Klebsiella antigens appear not to involve a  pyruvy- 
iated-DGal specificity. 
The coprecipitation experiment (Fig. 4) shows that the unique reactivity of IgM  wEA 
with the polysaccharides is associated with the  F(ab')2  fragment and not with the 
Fc~ fragment and, thus, is consistent with an antibody activity. The finding of the 
two human IgM macroglobulins with combining sites that react specifically with 3,4- 
and 4,6-pyruvylated-DGal again raises the question (12,  13) of whether the frequent 
occurrence of Klebsiella in the nasopharynx and gastrointestinal tract expands Klebsi- 
ella-specific  B  cell  clones  and  increases  the  probability  of finding dyscrasias  that 
involve a  cell synthesizing anti-Klebsiella antibody. The frequent occurrence in mice 
of myelomas with antibody activity directed against antigens of the intestinal bacteria, 
hardwood  bedding,  and  diet,  to  which  mice  are  continually  exposed,  has  been 
explained on  this basis  (61,  62).  The  failure to find a  high incidence of myeloma 
antibodies in man may reflect the types of antigen used in previous screening studies. 
Summary 
Two human IgM myeloma proteins, IgM  wzA and IgM  MAY, were found to react 
with agar and Klebsiella polysaccharides that contain pyruvylated D-galactose (oGal). 
Quantitative precipitin data and precipitin inhibition studies with methyl a- and fl- 
glycosides of 4,6-pyruvylated-D-galactose showed their combining sites to be different, 
although each was directed against the pyruvylated-o-Gal, one reacting most specif- 
ically with Klebsiella  polysaccharides with terminal nonreducing fl-linked 3,4 pyru- 992  KLEBSIELLA-SPECIFIC  HUMAN MONOCLONAL MACROCLOBULINS 
vylated-D-Gal, whereas the other reacted equally well with Klebsiella polysaccharides 
that  contain  3,4 fl-linked  and 4,6 a-linked  terminal  nonreducing pyruvylated-DGal. 
Inhibition  studies  showed  that  both  sites  are  directed  toward  one of the  two space 
isomers of 3,4- or 4,6-pyruvylated DGal, the form in which the methyl group of the 
pyruvate is equatorial,  or endo, and its carboxyl group axial, or exo, to the plane of 
the acetal ring.  Coprecipitation  studies showed the combining site of IgM  wEA to be 
located on an (Fab')2 fragment and not on the (Fc)s/~ fragment. The monoclonal peak 
in  the  serum  of IgM  MAY was  specifically  precipitated  by Klebsiella  polysaccharide. 
Myeloma proteins with specificities of this type may occur with reasonable frequency 
in humans and may be a consequence of clonal expansion from inapparent  infection, 
carrier states, or disease produced by various KlebsieUa  organisms. 
Received  for publication 6 May 1980 and in revised  form 25June 1980. 
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